ALCHEMIA
Alchemia Limited is a listed Australian biopharmaceutical company (ASX:ACL) with an FDA approved drug (Fondaparinux sodium) and a late stage oncology product pipeline derived from the HyACT platform. In addition, Alchemia has a drug discovery platform, VAST®, derived from Alchemia’s chemistry expertise.
ALCHEMIA
Industry:
Biopharma Biotechnology Health Care
Founded:
1995-01-01
Address:
Eight Mile Plains, Queensland, Australia
Country:
Australia
Website Url:
http://www.alchemia.com.au
Total Employee:
11+
Status:
Active
Contact:
61 7 3340 0200
Email Addresses:
[email protected]
Total Funding:
10.2 M AUD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Content Delivery Network Mobile Non Scaleable Content Nginx DigiCert SSL CloudFront OpenResty Google Adsense
Similar Organizations
Anthos Therapeutics
Anthos Therapeutics is a biopharmaceutical company that specializes in the treatment of cardiovascular and metabolic diseases.
Ascenta Therapeutics
Ascenta Therapeutics, a clinical-stage biopharmaceutical company, focuses on the discovery and development of new medicines to treat cancer.
Current Employees Featured
Stock Details
Company's stock symbol is ASX:ACL
Official Site Inspections
http://www.alchemia.com.au
- Host name: lb-182-246.above.com
- IP address: 103.224.182.246
- Location: Australia
- Latitude: -33.494
- Longitude: 143.2104
- Timezone: Australia/Sydney
Loading ... 